Omar Usmani (London, United Kingdom), Nicolas Roche (Paris, France), Paul Hagedoorn (Groningen, Netherlands)
Assessment of passive humidifier performance following on-ventilator aerosol therapy
Patrick Kelly (Galway, Ireland), Patrick Kelly, Andrew O’Sullivan, Louise Sweeney, Ronan Mac Loughlin
|   |
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy
Árpád Farkas (Budapest, Hungary), Árpád Farkas, Ágnes Jókay, Péter Füri, Imre Balásházy
| |
Edry™ an innovative dry powder technology evaluated via functional respiratory imaging (FRI)
Wim Vos (Heist-op-den-Berg, Belgium), Giovanni Caponetti, Loretta Maggi, Marco Sardina, Franco Castegini, Luca Raiteri, Isabella Salerio, Ioannis Kottakis, Cedric Van Holsbeke, Jan De Backer, Wim Vos
| |
Device handling study of a novel fluticasone propionate/formoterol breath-triggered inhaler
Mark Lomax (Cambridge, United Kingdom), David Bell, Lucielle Mansfield, Mark Lomax
| |
Reproducibility of inhaler use and pulmonary drug deposition in COPD
Tamás Erdélyi ( Budapest, Hungary), Tamás Erdélyi, Zsófia Lázár, Balázs Odler, Anikó Bohács, Noémi Eszes, Ágnes Jókay, Árpád Farkas, Imre Balásházy, Veronika Müller
| |
Novel jet nebulizer/holding chamber for drug delivery to the deep lung
Gerald Smaldone (Stony Brook, United States of America), Gerald Smaldone, Ashwin Gowda, Rohinton Toddywala
| |
Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI
Annalisa Piccinno (Parma, Italy), Annalisa Piccinno, Lisa D’Amato, Mario Scuri, Annamaria Muraro, Daniela Acerbi
| |
Inhalation technique in patients with obstructive pulmonary diseases- Most common mistakes and factors, favouring the correct technique
Zlatina Ivanova (Pleven, Bulgaria), Zlatina Ivanova, Iliya Krachunov, Nikolay Kyuchukov, Nikolay Yanev, Pavlina Glogovska, Plamen Pavlov, Tsania Popova, Yavor Ivanov
| |
Effect of antistatic AeroChamber Plus® Flow-Vu® spacer on the systemic bioavailability of CHF5993 a novel triple pMDI
Fabrizia Mariotti (Parma, Italy), Fabrizia Mariotti, Sara Collarini, Stefano Vezzoli, Daniela Acerbi, Mario Scuri, Piotr Kuna
| |
Stimulation with polyinosinic-polycytidylic acid (poly(I:C)) encapsulated within novel pH-sensitive switchable liposomes leads to a faster and more potent interferon response
Larry Lands (Montreal, Canada), Nurlan Dauletbaev, Maria Cammisano, Warren Viricel, Suli-Anne Laurin, Jeanne Leblond-Chain, Larry Lands
| |
Observation of the knowledge and use of inhalers in children
Christophe Goubau (Brussels, Belgium), Christophe Goubau, Nicolas Audag, Marie-Line Chanel, Veronique Godding, Giuseppe Liistro, Gregory Reychler
| |
Mesh nebulizer capabilities in aerosolizing a wide range of novel pharmaceutical formulations
Ross Hatley (Chichester, United Kingdom), Ross Hatley, Lucy Hardaker
| |
Z7200 versus Symbicort® Turbohaler®: A pharmacodynamic evaluation of the acute effects using functional respiratory imaging (FRI)
Wim Vos (Heist-op-den-Berg, Belgium), Wim Vos, Cedric Van Holsbeke, Jan De Backer, Giovanni Caponetti, Franco Castegini, Marco Sardina, Luca Raiteri, Isabella Salerio, Ioannis Kottakis, Johan Clukers, Wilfried De Backer
| |
Budesonide-formoterol Easyhaler®: Dose consistency under simulated real-life conditions
Jussi Haikarainen (Espoo, Finland), Jussi Haikarainen, Paula Rytilä, Sirpa Metsärinne, Anita Happonen
| |
Satisfaction survey on the use of breath actuated Inhaler
Neeraj Gupta (New Delhi, India), Neeraj Gupta, Ajay Darbar
| |
Impact of critical handling errors on delivered budesonide/formoterol dose in dry powder inhalers – An in vitro study
Gunilla Telg (Sodertalje, Sweden), Thomas Lööf, Gunilla Telg, Georgios Stratelis
| |
Inhaler preference comparing two alternative dual bronchodilator regimens
John Riley (Uxbridge, United Kingdom), John Riley, Amy Newlands, William Fahy, Mitra Vahdati-Bolouri, Margaret Tabberer
| |
In vitro validation of the use of a spacer with an extrafine beclomethasone/formoterol formulation
Emeline Furon (Valognes, France), Emeline Furon, Thierry Porée
| |
Deposition of inhaled nanoparticles, airflow obstruction and emphysema
Per Wollmer (Malmø, Sweden), Laura Aaltonen, Hanna Nicklasson, Jonas Jakobsson, Sophia Zackrisson, Jakob Löndahl, Per Wollmer
| |
Initial interaction of fluticasone propionate with ciliated respiratory epithelium
Dani Do Hyang Lee (London, United Kingdom), Dani Do Hyang Lee, Priya Radhakrishnan, Claire M. Smith, Chris O’Callaghan
| |